Nifty

:

25178.65

Sensex

:

81287.19

-317.90 (-1.25%)
-961.42 (-1.17%)

Login

Nifty
Sensex

:
:

25178.65
81287.19

-317.90 (-1.25%)
-961.42 (-1.17%)

Haleos Labs Ltd.

Pharmaceuticals & Drugs

Rating :

68/99

BSE: 540679 | NSE: HALEOSLABS

Watchlist

NSE BSE

1260.30

27-Feb-2026

Open
High
Low
Previous Close

1319
1319
1260
1312.50

Volume
Traded Value (lacs)
52 Week High
52 Week Low

693
876750.5
1680
959.8

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

397.86
20.04
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

464.02
0.11%
1.87

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
5.35
2.99

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
8.32
9.36

PAT CAGR (%)

10 Years
5 Years
3 Years

-
8.20
20.58

P:E (Median)

8 Years
5 Years
3 Years

-
17.07
20.65

P:BV (Average)

8 Years
5 Years
3 Years

-
1.51
1.54

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
8.76
9.31

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 80.72 82.88 -2.61% 77.84 78.50 -0.84% 79.04 86.57 -8.70% 85.43 86.37 -1.09%
Expenses 69.16 69.81 -0.93% 67.04 66.70 0.51% 68.21 72.80 -6.30% 79.83 75.56 5.65%
EBITDA 11.56 13.07 -11.55% 10.80 11.80 -8.47% 10.84 13.77 -21.28% 5.60 10.81 -48.20%
EBIDTM 14.32% 15.77% 13.87% 15.03% 13.71% 15.90% 6.55% 12.52%
Other Income 0.08 0.06 33.33% 0.44 1.26 -65.08% 1.01 0.43 134.88% 2.20 2.28 -3.51%
Interest 1.46 1.96 -25.51% 1.51 1.93 -21.76% 1.73 2.16 -19.91% 1.84 2.56 -28.12%
Depreciation 2.69 2.56 5.08% 2.68 2.57 4.28% 2.63 2.50 5.20% 2.62 2.62 0.00%
PBT 7.49 8.61 -13.01% 7.05 8.56 -17.64% 7.48 9.54 -21.59% 3.33 7.91 -57.90%
Tax 2.08 2.38 -12.61% 2.07 2.55 -18.82% 2.32 3.08 -24.68% 0.66 1.98 -66.67%
PAT 5.41 6.23 -13.16% 4.98 6.01 -17.14% 5.16 6.46 -20.12% 2.67 5.93 -54.97%
PATM 6.70% 7.51% 6.39% 7.65% 6.53% 7.46% 3.13% 6.87%
EPS 18.02 20.76 -13.20% 16.59 20.03 -17.17% 17.20 21.53 -20.11% 8.91 19.78 -54.95%

Description Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var% Mar 25 Mar 24 Var%
Net Sales 94.78 84.60 12.03% 81.37 78.46 3.71% 82.50 92.55 -10.86% 89.11 89.99 -0.98%
Expenses 80.73 71.85 12.36% 67.80 69.90 -3.00% 70.79 76.26 -7.17% 81.69 78.63 3.89%
EBITDA 14.05 12.75 10.20% 13.57 8.56 58.53% 11.71 16.28 -28.07% 7.42 11.36 -34.68%
EBIDTM 14.82% 15.08% 16.68% 10.91% 14.20% 17.60% 8.33% 12.62%
Other Income 0.18 0.06 200.00% 0.42 2.04 -79.41% 1.00 0.44 127.27% 2.34 2.36 -0.85%
Interest 1.54 2.14 -28.04% 1.61 2.14 -24.77% 1.86 2.41 -22.82% 2.03 2.84 -28.52%
Depreciation 3.91 3.76 3.99% 3.89 3.76 3.46% 3.82 3.68 3.80% 3.80 3.78 0.53%
PBT 8.78 6.92 26.88% 8.49 4.70 80.64% 7.02 10.64 -34.02% 3.93 7.10 -44.65%
Tax 2.13 2.06 3.40% 2.07 1.40 47.86% 2.64 3.54 -25.42% 0.45 0.63 -28.57%
PAT 6.65 4.85 37.11% 6.43 3.30 94.85% 4.38 7.10 -38.31% 3.48 6.48 -46.30%
PATM 7.01% 5.74% 7.90% 4.20% 5.31% 7.67% 3.91% 7.20%
EPS 21.89 18.08 21.07% 20.19 15.46 30.60% 13.75 22.99 -40.19% 9.83 19.53 -49.67%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 323.03 333.37 300.00 315.24 345.63 260.26 256.92 344.15 212.99 215.89 0.00 Net Sales Growth -3.38% 11.12% -4.83% -8.79% 32.80% 1.30% -25.35% 61.58% -1.34% 0 Cost Of Goods Sold 160.23 169.12 162.17 190.25 208.37 139.66 162.04 230.28 132.95 120.07 0.00 Gross Profit 162.80 164.25 137.84 124.99 137.25 120.60 94.88 113.87 80.04 95.82 0.00 GP Margin 50.40% 49.27% 45.95% 39.65% 39.71% 46.34% 36.93% 33.09% 37.58% 44.38% 0 Total Expenditure 284.24 289.08 265.46 288.77 314.21 230.45 233.12 311.69 199.76 187.40 0.00 Power & Fuel Cost - 27.17 26.46 25.66 26.32 19.52 18.73 24.11 21.09 21.56 0.00 % Of Sales - 8.15% 8.82% 8.14% 7.62% 7.50% 7.29% 7.01% 9.90% 9.99% 0 Employee Cost - 45.78 40.92 34.72 32.51 27.11 23.27 20.63 17.65 16.89 0.00 % Of Sales - 13.73% 13.64% 11.01% 9.41% 10.42% 9.06% 5.99% 8.29% 7.82% 0 Manufacturing Exp. - 29.35 24.88 24.72 32.65 27.62 19.26 23.98 18.73 20.77 0.00 % Of Sales - 8.80% 8.29% 7.84% 9.45% 10.61% 7.50% 6.97% 8.79% 9.62% 0 General & Admin Exp. - 6.00 5.37 7.44 6.85 6.60 5.45 5.38 4.91 1.91 0.00 % Of Sales - 1.80% 1.79% 2.36% 1.98% 2.54% 2.12% 1.56% 2.31% 0.88% 0 Selling & Distn. Exp. - 6.21 5.18 5.16 6.91 6.70 4.20 6.63 4.38 6.16 0.00 % Of Sales - 1.86% 1.73% 1.64% 2.00% 2.57% 1.63% 1.93% 2.06% 2.85% 0 Miscellaneous Exp. - 5.46 0.48 0.81 0.59 3.23 0.16 0.66 0.05 0.04 0.00 % Of Sales - 1.64% 0.16% 0.26% 0.17% 1.24% 0.06% 0.19% 0.02% 0.02% 0 EBITDA 38.80 44.29 34.54 26.47 31.42 29.81 23.80 32.46 13.23 28.49 0.00 EBITDA Margin 12.01% 13.29% 11.51% 8.40% 9.09% 11.45% 9.26% 9.43% 6.21% 13.20% 0 Other Income 3.73 3.95 3.84 2.88 1.54 1.33 1.88 2.53 3.08 1.73 0.00 Interest 6.54 7.94 9.01 5.16 4.68 4.57 5.10 5.46 4.21 6.20 0.00 Depreciation 10.62 10.26 10.25 8.17 7.99 7.21 7.24 5.77 5.70 5.55 0.00 PBT 25.35 30.04 19.11 16.02 20.28 19.35 13.34 23.76 6.40 18.46 0.00 Tax 7.13 8.67 6.05 5.15 7.60 6.19 4.19 7.13 -0.10 5.52 0.00 Tax Rate 28.13% 28.86% 31.66% 28.03% 23.05% 31.99% 31.41% 30.01% -1.56% 29.90% 0.00% PAT 18.22 21.37 13.07 13.22 25.38 13.17 9.15 16.63 6.50 12.94 0.00 PAT before Minority Interest 18.22 21.37 13.07 13.22 25.38 13.17 9.15 16.63 6.50 12.94 0.00 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.64% 6.41% 4.36% 4.19% 7.34% 5.06% 3.56% 4.83% 3.05% 5.99% 0 PAT Growth -26.03% 63.50% -1.13% -47.91% 92.71% 43.93% -44.98% 155.85% -49.77% 0 EPS 60.73 71.23 43.57 44.07 84.60 43.90 30.50 55.43 21.67 43.13 0.00

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Net Sales 347.76 344.72 305.96 315.56 350.07 265.59 260.78 377.85 Net Sales Growth 0.63% 12.67% -3.04% -9.86% 31.81% 1.84% -30.98% Cost Of Goods Sold 149.14 154.06 151.16 171.41 194.68 137.04 157.88 255.87 Gross Profit 198.62 190.66 154.80 144.16 155.39 128.55 102.90 121.98 GP Margin 57.11% 55.31% 50.59% 45.68% 44.39% 48.40% 39.46% 32.28% Total Expenditure 301.01 299.63 274.74 286.74 315.54 235.35 235.38 343.09 Power & Fuel Cost - 32.53 30.45 29.28 30.02 21.56 20.48 25.93 % Of Sales - 9.44% 9.95% 9.28% 8.58% 8.12% 7.85% 6.86% Employee Cost - 59.54 52.26 43.43 39.90 30.66 26.56 23.11 % Of Sales - 17.27% 17.08% 13.76% 11.40% 11.54% 10.18% 6.12% Manufacturing Exp. - 34.16 28.10 28.22 35.77 29.16 20.26 24.94 % Of Sales - 9.91% 9.18% 8.94% 10.22% 10.98% 7.77% 6.60% General & Admin Exp. - 7.56 7.05 8.32 7.47 6.95 5.69 5.84 % Of Sales - 2.19% 2.30% 2.64% 2.13% 2.62% 2.18% 1.55% Selling & Distn. Exp. - 6.32 5.23 5.25 6.97 6.75 4.30 6.74 % Of Sales - 1.83% 1.71% 1.66% 1.99% 2.54% 1.65% 1.78% Miscellaneous Exp. - 5.46 0.48 0.84 0.72 3.23 0.21 0.66 % Of Sales - 1.58% 0.16% 0.27% 0.21% 1.22% 0.08% 0.17% EBITDA 46.75 45.09 31.22 28.82 34.53 30.24 25.40 34.76 EBITDA Margin 13.44% 13.08% 10.20% 9.13% 9.86% 11.39% 9.74% 9.20% Other Income 3.94 4.86 3.83 3.07 1.74 1.78 2.28 2.51 Interest 7.04 8.77 10.26 6.87 6.23 4.60 5.15 5.51 Depreciation 15.42 15.00 14.94 10.79 10.01 7.86 7.86 6.38 PBT 28.22 26.19 9.85 14.24 20.04 19.57 14.67 25.39 Tax 7.29 7.46 3.52 5.22 7.43 6.01 4.48 7.54 Tax Rate 25.83% 28.48% 35.74% 31.46% 22.70% 30.71% 30.54% 29.70% PAT 20.94 20.11 9.10 11.47 25.32 13.56 10.18 17.85 PAT before Minority Interest 19.85 18.73 6.33 11.38 25.30 13.56 10.18 17.85 Minority Interest -1.09 1.38 2.77 0.09 0.02 0.00 0.00 0.00 PAT Margin 6.02% 5.83% 2.97% 3.63% 7.23% 5.11% 3.90% 4.72% PAT Growth -3.64% 120.99% -20.66% -54.70% 86.73% 33.20% -42.97% EPS 69.80 67.03 30.33 38.23 84.40 45.20 33.93 59.50

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 197.18 176.23 164.03 151.21 126.34 113.26 104.98 88.41 81.84 0.00 Share Capital 3.02 3.02 3.02 3.02 3.02 3.02 3.02 3.02 0.01 0.01 Total Reserves 194.15 173.20 161.00 148.19 123.31 110.23 101.96 85.38 81.83 -0.01 Non-Current Liabilities 36.84 48.45 62.80 41.83 40.41 35.93 37.42 24.36 25.41 0.00 Secured Loans 17.31 28.31 42.37 21.90 16.68 18.72 21.83 9.12 14.84 0.00 Unsecured Loans 0.00 0.00 3.60 4.95 4.95 4.95 5.38 6.08 1.13 0.00 Long Term Provisions 4.20 4.02 3.62 3.25 2.93 2.59 2.24 2.00 1.83 0.00 Current Liabilities 133.30 126.89 114.07 126.17 109.39 82.59 114.44 65.25 74.00 0.01 Trade Payables 45.98 49.54 54.53 70.85 61.63 45.33 83.83 44.39 55.40 0.01 Other Current Liabilities 26.25 24.71 24.65 18.71 21.50 12.22 10.95 12.56 7.67 0.00 Short Term Borrowings 50.46 46.76 30.11 27.14 20.20 20.96 12.77 5.99 4.04 0.00 Short Term Provisions 10.59 5.89 4.78 9.47 6.07 4.08 6.90 2.30 6.89 0.00 Total Liabilities 367.32 351.57 340.90 319.21 276.14 231.78 256.84 178.02 181.25 0.01 Net Block 150.23 138.23 139.61 98.72 100.83 94.50 87.13 68.38 72.68 0.00 Gross Block 212.53 191.08 183.11 127.71 130.82 118.16 104.26 79.79 78.34 0.00 Accumulated Depreciation 62.30 52.85 43.50 28.99 29.99 23.67 17.13 11.41 5.67 0.00 Non Current Assets 180.52 172.88 169.80 149.68 136.32 127.74 121.00 87.94 81.34 0.00 Capital Work in Progress 0.40 6.00 0.85 21.21 3.16 2.47 1.31 7.09 0.17 0.00 Non Current Investment 23.23 23.23 23.23 23.24 25.81 25.81 25.81 5.00 0.04 0.00 Long Term Loans & Adv. 6.66 5.42 6.10 6.52 6.52 4.96 4.78 6.65 7.64 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 1.05 0.01 0.01 0.00 Current Assets 186.79 178.68 171.09 169.52 139.83 104.03 135.84 90.07 99.90 0.00 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 60.58 74.59 80.46 81.36 58.76 61.05 73.87 49.32 43.79 0.00 Sundry Debtors 64.53 49.35 45.52 33.77 29.99 22.02 36.58 27.08 39.03 0.00 Cash & Bank 1.41 1.26 0.95 2.14 8.90 2.30 2.47 0.76 0.08 0.00 Other Current Assets 60.28 1.50 2.20 2.75 42.17 18.66 22.92 12.92 17.00 0.00 Short Term Loans & Adv. 59.91 51.99 41.96 49.51 41.46 13.55 12.59 11.81 15.77 0.00 Net Current Assets 53.49 51.79 57.03 43.35 30.44 21.44 21.39 24.83 25.90 -0.01 Total Assets 367.31 351.56 340.89 319.20 276.15 231.77 256.84 178.01 181.24 0.01

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Shareholder's Funds 196.56 176.81 168.61 152.23 129.22 115.73 106.33 Share Capital 3.02 3.02 3.02 3.02 3.02 3.02 3.02 Total Reserves 193.54 173.79 165.59 149.21 126.19 112.71 103.31 Non-Current Liabilities 35.88 52.32 73.11 56.38 59.00 50.06 38.60 Secured Loans 18.27 33.15 51.34 35.38 34.19 31.76 21.83 Unsecured Loans 0.00 0.00 3.60 4.95 4.95 4.95 5.38 Long Term Provisions 5.13 4.74 4.10 3.51 3.04 2.70 2.33 Current Liabilities 151.07 148.81 137.06 143.06 118.76 90.10 131.56 Trade Payables 53.27 59.13 59.67 77.89 67.03 49.03 97.91 Other Current Liabilities 36.71 37.01 42.48 28.55 25.44 15.57 13.59 Short Term Borrowings 50.46 46.76 30.11 27.14 20.20 20.96 12.77 Short Term Provisions 10.62 5.91 4.80 9.48 6.09 4.54 7.30 Total Liabilities 399.00 394.76 398.38 364.37 306.98 255.89 276.49 Net Block 231.85 223.34 228.36 142.03 129.78 124.13 117.43 Gross Block 312.24 289.58 280.62 177.21 164.01 149.59 135.78 Accumulated Depreciation 80.39 66.24 52.26 35.18 34.24 25.47 18.34 Non Current Assets 239.42 235.25 235.77 200.73 176.01 145.61 127.63 Capital Work in Progress 0.40 6.00 0.85 51.18 38.31 15.76 3.29 Non Current Investment 0.04 0.04 0.04 0.04 0.04 0.04 0.04 Long Term Loans & Adv. 7.13 5.87 6.53 7.48 7.88 5.68 4.90 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 1.05 Current Assets 159.57 159.52 162.62 163.64 130.97 110.28 148.86 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 67.40 81.21 86.23 84.81 61.63 64.30 81.17 Sundry Debtors 68.79 51.35 46.06 33.83 34.15 21.61 41.32 Cash & Bank 1.51 1.49 4.41 4.39 11.06 7.59 2.61 Other Current Assets 21.88 1.82 2.56 2.99 24.13 16.78 23.76 Short Term Loans & Adv. 21.24 23.65 23.35 37.62 23.30 11.13 13.05 Net Current Assets 8.51 10.71 25.55 20.57 12.21 20.18 17.30 Total Assets 398.99 394.77 398.39 364.37 306.98 255.89 276.49

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 28.03 14.75 4.58 -14.66 21.62 13.95 27.26 8.00 19.66 0.00 PBT 30.04 19.11 16.02 20.28 19.35 13.34 23.76 6.40 18.46 0.00 Adjustment 18.85 15.40 11.51 10.52 9.89 10.62 8.65 7.98 8.68 0.00 Changes in Working Capital -12.36 -16.76 -19.45 -37.90 -3.02 -7.18 1.20 -5.62 -2.45 0.00 Cash after chg. in Working capital 36.53 17.75 8.08 -7.10 26.23 16.77 33.62 8.75 24.69 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -8.50 -3.00 -3.50 -7.56 -4.61 -2.82 -6.35 -0.75 -5.03 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -13.77 -13.75 -27.96 -7.49 -5.94 -13.28 -43.27 -6.84 -7.53 0.00 Net Fixed Assets -15.85 -13.12 -35.04 -14.94 -13.35 -15.06 -18.69 -8.37 -78.51 Net Investments 0.00 0.00 0.01 2.57 0.00 0.00 -20.81 -4.96 -0.04 Others 2.08 -0.63 7.07 4.88 7.41 1.78 -3.77 6.49 71.02 Cash from Financing Activity -14.20 -0.82 22.59 14.63 -7.87 -2.05 17.60 -0.81 -12.34 0.00 Net Cash Inflow / Outflow 0.07 0.18 -0.80 -7.52 7.81 -1.38 1.60 0.36 -0.21 0.00 Opening Cash & Equivalents 0.33 0.15 0.95 8.46 0.65 2.03 0.44 0.08 0.29 0.00 Closing Cash & Equivalent 0.40 0.33 0.15 0.95 8.46 0.65 2.03 0.44 0.08 0.00

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Cash From Operating Activity 34.05 24.31 14.70 -11.24 35.17 14.55 29.99 PBT 26.19 9.85 14.24 20.04 19.57 14.67 25.38 Adjustment 24.72 21.49 15.87 14.05 10.38 11.24 9.34 Changes in Working Capital -8.36 -4.03 -12.15 -37.62 10.16 -8.30 1.94 Cash after chg. in Working capital 42.55 27.31 17.95 -3.53 40.10 17.61 36.67 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -8.50 -3.00 -3.26 -7.71 -4.93 -3.06 -6.67 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -15.00 -18.45 -31.29 -7.14 -26.23 -27.02 -44.01 Net Fixed Assets -15.85 -13.12 -35.04 -14.94 -13.35 -15.06 Net Investments 0.00 0.00 0.01 2.57 0.00 0.00 Others 0.85 -5.33 3.74 5.23 -12.88 -11.96 Cash from Financing Activity -19.12 -6.56 16.89 10.83 -2.55 12.45 15.37 Net Cash Inflow / Outflow -0.07 -0.71 0.29 -7.55 6.39 -0.03 1.35 Opening Cash & Equivalents 0.57 1.28 0.99 8.54 2.15 2.17 0.82 Closing Cash & Equivalent 0.50 0.57 1.28 0.99 8.54 2.15 2.17

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 652.19 582.90 542.55 500.16 417.88 374.61 347.23 292.42 81838.70 -8.21 ROA 5.95% 3.77% 4.00% 8.53% 5.19% 3.74% 7.65% 3.62% 14.28% -14.76% ROE 11.45% 7.68% 8.39% 18.29% 10.99% 8.38% 17.20% 7.64% 31.63% 0.00% ROCE 14.03% 10.94% 10.23% 19.73% 14.36% 11.73% 21.82% 9.48% 45.72% 0.00% Fixed Asset Turnover 1.83 1.76 2.26 2.93 2.30 2.54 4.08 2.98 2.91 0.00 Receivable days 56.42 52.66 41.13 30.70 33.09 37.84 30.92 51.23 62.50 0.00 Inventory Days 66.97 86.07 83.93 67.45 76.21 87.13 59.84 72.17 70.13 0.00 Payable days 103.08 117.11 120.26 116.03 139.78 145.46 71.86 85.97 52.79 0.00 Cash Conversion Cycle 20.31 21.63 4.79 -17.88 -30.47 -20.50 18.90 37.43 79.85 0.00 Total Debt/Equity 0.40 0.50 0.52 0.40 0.35 0.43 0.45 0.31 0.32 -0.37 Interest Cover 4.78 3.12 4.56 8.05 5.24 3.61 5.35 2.52 3.98 0.00

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19
Book Value (Rs.) 650.15 584.84 557.71 503.53 427.40 382.80 351.70 ROA 4.72% 1.60% 2.98% 7.54% 4.82% 3.83% 6.45% ROE 10.03% 3.66% 7.09% 17.98% 11.07% 9.17% 16.78% ROCE 12.60% 7.42% 9.45% 18.42% 12.96% 11.91% 20.14% Fixed Asset Turnover 1.28 1.19 1.56 2.28 1.88 2.04 3.07 Receivable days 56.81 52.44 40.71 31.92 34.48 39.53 36.22 Inventory Days 70.27 90.14 87.15 68.75 77.87 91.38 71.14 Payable days 133.15 143.42 146.47 135.85 154.56 169.86 99.23 Cash Conversion Cycle -6.07 -0.85 -18.60 -35.18 -42.21 -38.95 8.13 Total Debt/Equity 0.43 0.55 0.59 0.51 0.50 0.55 0.44 Interest Cover 3.99 1.96 3.42 6.26 5.26 3.85 5.61

Top Investors:

harita projects private

bharadhwajan jaganathan velamur

Annual Reports:

News Update:

Haleos Labs enters into strategic Development collaboration with HRV Global
21st Jan 2026, 15:29 PM

The company will leverage its USFDA-GMP aligned systems and API manufacturing expertise
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback